Patient Buzz Series: Dermatology Post-Quarantine
EPI Health has graciously supported the COVID-19 News and Resource Center.
As states begin easing restrictions, this month’s Patient Buzz includes several articles on how to care for the skin post-quarantine. Are mask-off injectable treatments safe for patients and providers? What skin, hair and nail concerns need an in-person visit, and what can be addressed virtually? How will COVID-19 for …
EPI Health has graciously supported the COVID-19 News and Resource Center.
As states begin easing restrictions, this month’s Patient Buzz includes several articles on how to care for the skin post-quarantine. Are mask-off injectable treatments safe for patients and providers? What skin, hair and nail concerns need an in-person visit, and what can be addressed virtually? How will COVID-19 for … Continue reading "Patient Buzz Series: Dermatology Post-Quarantine"
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-AD (Surveillance Epidemiology of Corona Virus (COVID-19) Under Research Exclusion - Atopic Dermatitis) is a secure, online, de-identified international reporting registry for health care providers to report outcomes of COVID-19 in atopic dermatitis (AD) patients.
Clinicians worldwide are encouraged to report al … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
USA TODAY and countless other media outlets have recently covered a dermatological phenomenon called COVID toes. Are COVID toes a true skin manifestation of COVID-19?
For an expert opinion, I consulted dermatologist Amy McMichael, MD, professor and chair of the department of dermatology, Wake Forest Baptist Medical Ce … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
SECURE-Alopecia is a physician-entered patient registry to record COVID-19 positive alopecia patient outcomes, on or off treatment, with scarring and non-scarring alopecia. Clinicians worldwide are encouraged to report ALL cases of COVID-19 in their alopecia patients treated with antimalarials, JAK inhibitors (given the … 
EPI Health has graciously supported the COVID-19 News and Resource Center.
On April 22nd, 2020, the Journal of Drugs in Dermatology, Derm In-Review, and the George Washington School of Medicine and Health Sciences hosted a live webinar to answer resident concerns during the global coronavirus pandemic. The webinar was moderated by Dr. Adam Friedman, Professor and Interim Chair of Dermatology a … 